CNBC - Health
FDA approves Amgen's treatment for most deadly form of lung cancer
16 hours ago
Roche says weight loss drug shows promising results in early trial21 hours ago
Danaher shows how sticking with a troubled stock of a good company can pay off21 hours ago
Walgreens to offer cheaper version of opioid overdose reversal drug naloxone1 day ago
Healthy Returns: 1 in 8 adults have taken Ozempic or other GLP-1s: Survey1 day ago
It's no surprise to see Amazon shares lower after cloud CEO shakeup2 days ago
People on Novo Nordisk's Wegovy maintain weight loss for up to four years: Study2 days ago
'Wealth can be pretty isolating': Problems that rich people face, according to therapists3 days ago
Novavax stock jumps 50% as Sanofi vaccine deal kicks off a turnaround3 days ago
Paid time off for pregnant women could become national movement, led by New York3 days ago
Goldman, American Express are among top companies for parents, new study shows4 days ago
Moderna says FDA delayed RSV vaccine approval to end of May7 days ago
Novavax partners with Sanofi to commercialize Covid vaccine, develop combo shots7 days ago
Shareholders push casinos to reassess indoor smoking7 days ago
Neuralink says its in-human brain implant has encountered a problem7 days ago
AstraZeneca to withdraw Covid vaccine worldwide, citing a drop in demand8 days ago
Healthy Returns: Eli Lilly, Novo Nordisk are boosting weight loss drug supply8 days ago
New rivals could threaten Novo Nordisk, Eli Lilly's weight loss drug dominance9 days ago
Elizabeth Holmes sees more months trimmed from prison release date10 days ago
Amgen stock soars on weight loss drug progress as Novo Nordisk, Eli Lilly slide10 days ago
Amgen scraps experimental weight loss pill, moves forward with injection14 days ago
Moderna loses less than expected as Covid vaccine sales beat, cost cuts take hold14 days ago
One-third of Americans could be impacted by Change Healthcare cyberattack15 days ago
UnitedHealth CEO tells lawmakers the company paid hackers a $22 million ransom15 days ago
Healthy Returns: Humira sales are plunging, but AbbVie has two successors15 days ago
Pfizer raises profit outlook on cost cuts and strong non-Covid sales15 days ago
CVS shares plummet 18% as health company slashes profit outlook15 days ago
J&J to pay $6.5 billion to resolve nearly all talc ovarian cancer lawsuits in U.S.16 days ago
Doctors tap personal savings to pay costs from Change Healthcare cyberattack16 days ago
Jim Cramer says GEHC's unwarranted post-earnings plunge is a buying opportunity16 days ago
Lilly assures investors it can overcome the high-quality problem of too much demand16 days ago
FTC challenges 'junk' patents held by 10 drugmakers, including for Ozempic16 days ago
Walmart to close health centers, virtual care in latest failed health-care push16 days ago
Eli Lilly beats on profit, hikes guidance on strong sales of Zepbound, Mounjaro17 days ago